secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spyre Therapeutics, Inc. (SYRE)
CIK:        0001636282
Form:       8-K/A
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001636282-24-000058
Event type: other_material
Sentiment:  neutral
Materiality: 0.00
LLM model:  deepseek-v4-flash:cloud@v2

Spyre Therapeutics files 8-K/A to correct date on cover page of prior filing
----------------------------------------------------------------------------

- Amendment corrects clerical error on cover page date of Original 8-K filed August 7, 2024.
- No changes to financial results, disclosures, or exhibits from the original report.
- Original 8-K reported Q2 2024 financials; this filing only revises the report date.
- No new material information for investors; purely administrative correction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636282/000163628224000058/0001636282-24-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636282/000163628224000058/syre-20240807.htm
  HTML page:      https://secwatch.observer/filing/0001636282-24-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer